BioCentury
ARTICLE | Clinical News

T-82: Phase I update

January 10, 2000 8:00 AM UTC

Arena Pharmaceuticals Inc., San Diego, Calif. Product: T-82 Business: Neurological Therapeutic category: Neurotransmission Target: Acetylcholinesterase Description: Acetylcholinesterase inhibitor and...